Saxenda Now Approved




Brand: Saxenda (liraglutide), Injection
Parent Company: Novo Nordisk
Drug Type: Prescription
Drug Category: Nutrition and Weight Loss
Campaign: now-approved
Targeting: Patients
Patient Website: https://www.saxenda.com/
HCP Website: https://www.saxendapro.com/

Submitted by: OnceDailyPharma

Leave a Reply

Your email address will not be published.